CIK 0001691082 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
LB PHARMACEUTICALS INC
Sign in to watch- Ticker
- LBRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 917-450-6581
- Business address
- 575 MADISON AVENUE, NEW YORK, NY, 10022
- Former names
- LB PHARMACEUTICALS INC.
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure · Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13D Stake Beneficial Ownership Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13D Stake Beneficial Ownership Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
Page 4 of 8 · 143 filings